Health

#SFHS2608157VNotice on Pharmaceutical Specialty Prices

🇫🇷France··Other·Medium Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This notice sets pharmaceutical prices in France for specific medications produced by companies such as SANDOZ, TEVA SANTE, and others. Prices are established through agreements and are effective a few days after publication in the official journal.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Establishment of drug prices
  • Prices apply to specific medications
  • Prices effective shortly after publication

Obligations

What this law requires

high

Apply the established pharmaceutical prices (PFHT and PPTTC) for all specified medications as listed in the price table, including BRIVARACETAM ZENTIVA (25mg, 50mg, 75mg, 100mg), FAMPRIDINE SANDOZ LP, FAMPRIDINE ZENTIVA LP, FUROSEMIDE TEVA SANTE, and ZOLESTAD products

SANDOZ, TEVA SANTE, ZENTIVA FRANCE, EG LABO LABORATOIRES EUROGENERICS and all entities distributing or selling these pharmaceutical products in France
operational
high

Implement price changes effective on the fourth day following publication in the Journal officiel de la République française

SANDOZ, TEVA SANTE, ZENTIVA FRANCE, EG LABO LABORATOIRES EUROGENERICS and all pharmaceutical distributors
operational
high

Maintain compliance with the economic conventions agreed between the Comité économique des produits de santé and the named pharmaceutical companies

SANDOZ, TEVA SANTE, ZENTIVA FRANCE, EG LABO LABORATOIRES EUROGENERICS
operational

Affected Parties

Pharmaceutical companiesHealthcare providers

Tags

pharmaceuticals,pricing,healthcare